Sun Biomedical to ¡§power¡¨ BioScreens, Inc.
Innovative Urine Drug Test
Blackwood, NJ, November 2008¡XSun Biomedical Laboratories Inc. (SBL) recently announced an initial
USD68,000 order of its patented Visualine„¥ urine drug test strips by BioScreens, Inc. of Norfolk, VA.
BioScreens, Inc. has developed an innovative split specimen urine test cup that is powered by SBL¡¦s
proprietary and patented Visualine„¥ test strips. This is the first substantial order following a distribution
agreement between the two companies announced earlier this year. Under the agreement, Sun Biomedical
develops and manufactures the membranes, while BioScreens manufactures the collection devices, as well
as markets and distributes the finished product.
¡§Partnering with a seasoned direct marketer, like BioScreens, allows us to provide premium membranes to
the growing workplace drug testing market in the U.S.,¡¨ stated Jack Kerins, CEO of Sun Biomedical. ¡§This
agreement reinforces our strategy of partnering with well-established market leaders who have an
expansive distribution channel.¡¨
The BioScreens CR3 Urine Split Specimen Cup will be available for volume delivery in January 2009.
Add to My Watchlist
What is My Watchlist?